Lexicon Pharmaceuticals
LXRX
LXRX
109 hedge funds and large institutions have $846M invested in Lexicon Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $1.12B → $846M (-$274M)
Holders
109
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.74M | |
| 2 | +$5.67M | |
| 3 | +$3.78M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.02M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$4.13M | |
| 3 | -$2.02M | |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.16M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$972K |